<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912804/" ref="ordinalpos=202&amp;ncbi_uid=5822246&amp;link_uid=PMC3912804" image-link="/pmc/articles/PMC3912804/figure/F6/" class="imagepopup">Figure 2d.  From: Hedgehog <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas. </a></div><br /><div class="p4l_captionBody">Hedgehog signaling pathway in cancers -Type IIIb-Reverse Paracrine Ligand-dependent cancers</div></div>